SavedAdd your journal

Journals / Medicine Science / 2017 / Cilt: 6 - Sayı: 4

Medication adherence of patients with chronic diseases: a study in the Black Sea region of Turkey

Kürşad YAPAR
Pages
620–628
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Informing the patients about the characteristics of the treatment, the medications, and the effects of the treatment on the disease increases the medication adherence of the individuals with chronic diseases

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic diseases are among the most common causes of morbidity and mortality in the world.
📊
Key Findings & Data:The data collection is performed with a questionnaire form with questions on socio-demographic features and on the chronic illness, and with the Morisky Medication Adherence Scale-8. 68% of the patients who participated in the study were female and 32% of them were male.
💡
Conclusion & Impact:Informing the patients about the characteristics of the treatment, the medications, and the effects of the treatment on the disease increases the medication adherence of the individuals with chronic diseases
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Chronic diseases are among the most common causes of morbidity and mortality in the world. Chronic diseases can be controlled and their frequencies can be reduced through fight against risk factors such as obesity, smoking, and insufficient physical exercise; early diagnosis, and appropriate treatment. In this study, we aim to assess the medication adherence of individuals with chronic diseases. In this descriptive study, the sample includes individuals who have been diagnosed with chronic diseases and who have applied to a public hospital. The data collection is performed with a questionnaire form with questions on socio-demographic features and on the chronic illness, and with the Morisky Medication Adherence Scale-8. 68% of the patients who participated in the study were female and 32% of them were male. It has been found that 51.4% of the patients (5.35±2.5) had low medication adherence. For those patients who have stated that they got information regarding the treatment and who had high levels of belief that the treatment could help them control the disease, the medication adherence score was significantly higher (p<0.05). Informing the patients about the characteristics of the treatment, the medications, and the effects of the treatment on the disease increases the medication adherence of the individuals with chronic diseases

🔖

Cite This Article

YAPAR, K. (2017). Medication adherence of patients with chronic diseases: a study in the Black Sea region of Turkey. Medicine Science, Cilt: 6 - Sayı: 4, 620–628. https://ajindex.com/articles/277436

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E, Hay SI, Mills EJ, Trickey A, Msemburi W, Coates MM. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980- 2015. Lancet Hiv. 2016
  2. e361-87 2. Kharsany AB, Karim QA. HIV infection and AIDS in Sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016
  3. UNAIDS. Report on the Global AIDS Epidemic. 2013. www.unaids.org/ sites/default/files/media./UNAIDS_GlobalReportַ_2013 access date 27.03.2017 4. HIV/AIDS Ethiopia - WHO/Regional Office for Africa 2014. www.afro. who.int. access date 29.03.2017 5. Kumarasamy N, Solomon S, Chauguturu S, Cecelia A, Flanigan T, Mayer KH. The changing natural history of HIV disease before and after the introduction of generic antiretroviral therapy in Southern India. Clin Infect Dis. 2005
  4. Kumarasamy N, Patel A and Pujari S. Antiretroviral therapy in Indian setting: When and what to start with, when & what to switch to? Review, Indian J Med Res. 2011
  5. Hammer SM. increasing choices for HIV therapy. N Engl J Med. 2002
  6. Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society–USA Panel. Jama. 2014
  7. 312(4):410-25. 9. Lima DGL, Arruda GE, Fonteles MM. Factors determining changes in initial antiretroviral therapy in Brazil. Rev Assoc Med Bras. 2012
  8. 58(2):222-8. 10. Monforte AD, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, Angarano G, Colangeli V, De Luca A, Ippolito G, Caggese L. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients. AIDS. 2000
  9. 14(5):499-507. 11. O’Brien ME, Clark RA, Besch CL, Myers L, Kissinger P. Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort in New Orleans, LA, USA. J Acquire Immune Defic Syndr. 2003
  10. Ammassari A. Self-reported symptoms and medication side effects influence adherence to HAART in persons with HIV infections. J Acquir Immune Deficit Syndr. 2001
  11. Sivadasan A. High rates of regimen change due to drug Toxicity among Cohort of South Indian Adults with HIV Infection Initiated on Generic, First-Line Antiretr